✦ LIBER ✦

2058 POSTER Factors influencing survival of 107 HER2 positive breast cancer patients treated with trastuzumab based neoadjuvant chemotherapy

✍ Scribed by L. Favier; S. Guiu; E. Dunach; D. Assous; F. Bonnetain; J. Gligorov; V. Stockmeier; B. Vasseur; P. Fumoleau; B. Coudert

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical expression of HER1,

✍ Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Akihiro Hirakawa; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

Survival of HER2-positive primary breast

✍ Takada, M.; Ishiguro, H.; Nagai, S.; Ohtani, S.; Kawabata, H.; Yanagita, Y.; Hoz 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 638 KB

The influence of PREDICT on chemotherapy

✍ Down, Sue; Lucas, Olivia; Benson, John; Wishart, Gordon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Pathological responses and survival of p

✍ Hideyuki Ohzawa, Takashi Sakatani, Toshiro Niki, Yoshikazu Yasuda… 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 269 KB

Extended survival of a HER-2-positive me

✍ Mariantonietta Colozza; Elisa Minenza; Stefania Gori; Daniela Fenocchio; Cristin 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 156 KB

Trastuzumab Emtansine: A Review of Its U

✍ Dhillon, Sohita 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 402 KB